Emergent BioSolutions Inc.
EBSNYSECIK 1367644HealthcareFiscal year ends Dec 31
Reports and events: 405 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-02-1507:06 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000021 |
| 2023-01-0906:55 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000004 |
| 2023-01-0517:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000002 |
| 2022-12-0607:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-22-000152 |
| 2022-11-0918:19 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001367644-22-000144 |
| 2022-11-0816:52 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-22-000141 |
| 2022-09-2617:05 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-22-000135 |
| 2022-08-1217:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-22-000132 |
| 2022-08-0318:19 ET | 8-K/A | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-22-000128 |
| 2022-08-0218:02 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001367644-22-000119 |
| 2022-08-0116:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-22-000116 |
| 2022-07-0616:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-22-000105 |
| 2022-06-0706:43 ET | 8-K | 1.02 Termination of a material agreement | 0001367644-22-000099 |
| 2022-06-0608:03 ET | 8-K | 8.01 Other events | 0001367644-22-000096 |
| 2022-05-2708:29 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-22-000080 |
| 2022-05-1817:13 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001367644-22-000075 |
| 2022-05-1606:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-22-000072 |
| 2022-04-2917:44 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001367644-22-000070 |
| 2022-04-2816:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-22-000067 |
| 2022-04-1516:51 ET | DEF 14A | Proxy statementPeriod 2022-05-26 | 0001193125-22-106880 |
| 2022-03-2316:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-22-000051 |
| 2022-02-2516:35 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001367644-22-000024 |
| 2022-02-2416:22 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-22-000012 |
| 2022-02-2216:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-22-000009 |
| 2022-01-1406:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-22-000006 |
| 2022-01-1006:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-22-000002 |
| 2021-11-1208:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-21-000139 |
| 2021-11-0516:51 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001367644-21-000137 |
| 2021-11-0416:19 ET | 8-K | 1.02 Termination of a material agreement | 0001367644-21-000133 |
| 2021-11-0416:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-21-000131 |
| 2021-10-0120:14 ET | 8-K | 1.01 Entry into a material agreement | 0001367644-21-000128 |
| 2021-09-0916:33 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001367644-21-000123 |
| 2021-07-3019:08 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001367644-21-000115 |
| 2021-07-2916:26 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-21-000112 |
| 2021-07-2216:50 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001367644-21-000110 |
| 2021-07-1406:27 ET | 8-K | 1.01 Entry into a material agreement | 0001367644-21-000107 |
| 2021-05-2516:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-21-000099 |
| 2021-05-1208:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-21-000083 |
| 2021-04-3018:01 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001367644-21-000073 |
| 2021-04-2916:24 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-21-000070 |
| 2021-04-2113:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-21-000068 |
| 2021-04-1906:20 ET | 8-K | 8.01 Other events | 0001367644-21-000066 |
| 2021-04-0916:04 ET | DEF 14A | Proxy statementPeriod 2021-04-09 | 0001367644-21-000061 |
| 2021-04-0507:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-21-000059 |
| 2021-04-0117:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-21-000053 |
| 2021-02-1918:52 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001367644-21-000033 |
| 2021-02-1816:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001367644-21-000030 |
| 2021-02-1616:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001367644-21-000020 |
| 2021-01-1106:34 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-21-000002 |
| 2020-11-0618:54 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001367644-20-000163 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.